HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I A Cree Selected Research

I A Cree Research Topics

Disease

11Melanoma (Melanoma, Malignant)
06/2007 - 06/2000
8Uveal melanoma
07/2006 - 06/2000
5Ovarian Neoplasms (Ovarian Cancer)
10/2013 - 05/2000
4Neoplasms (Cancer)
07/2011 - 07/2000
3Diabetic Retinopathy (Retinopathy, Diabetic)
02/2008 - 04/2005
2Colorectal Neoplasms (Colorectal Cancer)
07/2011 - 12/2003
2Carcinoma (Carcinomatosis)
07/2011 - 11/2000
2Acanthamoeba Keratitis
10/2009 - 03/2001
2Retinal Perforations
02/2008 - 04/2005
2Cataract (Cataracts)
06/2006 - 07/2000
2Monosomy
12/2000 - 10/2000
1Adenoma (Adenomas)
07/2011
1Polyps
07/2011
1Ulcer
10/2009
1Leukostasis
02/2008
1Neoplasm Metastasis (Metastasis)
06/2007
1Macular Degeneration (Age-Related Maculopathy)
06/2006
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2003
1Retinal Detachment (Retinal Detachments)
04/2002
1Melanosis (Freckles)
10/2001
1Dry Eye Syndromes (Dry Eye Syndrome)
04/2001
1Inflammation (Inflammations)
03/2001
1Infections
03/2001
1Orbital lymphoma
12/2000
1Cardiotoxicity
11/2000
1Ovarian Epithelial Carcinoma
05/2000

Drug/Important Bio-Agent (IBA)

5Adenosine Triphosphate (ATP)IBA
04/2002 - 05/2000
4CytokinesIBA
02/2008 - 04/2002
4GemcitabineFDA Link
06/2005 - 11/2000
3treosulfanIBA
06/2005 - 07/2000
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2005 - 04/2002
3Paclitaxel (Taxol)FDA LinkGeneric
12/2001 - 05/2000
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2001 - 10/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2006 - 04/2002
2Drug CombinationsIBA
12/2001 - 05/2000
2Mitoxantrone (Novantrone)FDA LinkGeneric
12/2001 - 10/2000
2AntigensIBA
10/2001 - 03/2001
2Pharmaceutical PreparationsIBA
04/2001 - 05/2000
2AnthracyclinesIBA
11/2000 - 10/2000
2Cisplatin (Platino)FDA LinkGeneric
07/2000 - 05/2000
1ErbB Receptors (EGF Receptor)IBA
10/2013
1ZSTK474IBA
10/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2013
1Gefitinib (Iressa)FDA Link
10/2013
1Sirolimus (Rapamycin)FDA Link
10/2013
1DNA (Deoxyribonucleic Acid)IBA
07/2011
1Genetic Markers (Genetic Marker)IBA
07/2011
1PlatinumIBA
08/2010
1Endothelin-1 (Endothelin 1)IBA
02/2008
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2008
1VaccinesIBA
06/2007
1EnzymesIBA
06/2007
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
06/2007
1Interleukin-10 (Interleukin 10)IBA
06/2007
1Transforming Growth Factor-beta Type I ReceptorIBA
06/2007
1Protons (Proton)IBA
07/2006
1Angiopoietin-1IBA
04/2005
1Angiopoietin-2IBA
04/2005
1AngiopoietinsIBA
04/2005
1Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2003
1Transforming Growth Factor alpha (TGF-alpha)IBA
10/2002
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
04/2002
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2002
1AntibodiesIBA
04/2002
1Vinorelbine (Navelbine)FDA LinkGeneric
12/2001
1Cytotoxins (Cytolysins)IBA
12/2001
1Formaldehyde (Formol)FDA Link
10/2001
1Transforming Growth Factor beta (TGF-beta)IBA
12/2000
1liposomal doxorubicin (Doxil)FDA Link
11/2000
1Alkylating AgentsIBA
11/2000
1Topoisomerase II InhibitorsIBA
10/2000
1Type II DNA Topoisomerases (Topoisomerase II)IBA
10/2000
1Vincristine (Oncovin)FDA LinkGeneric
10/2000
1Protein Isoforms (Isoforms)IBA
10/2000
1acridine DACAIBA
07/2000
1ApoferritinsIBA
07/2000
1Topoisomerase InhibitorsIBA
07/2000
1Carboplatin (JM8)FDA LinkGeneric
05/2000
1Epirubicin (Ellence)FDA LinkGeneric
05/2000
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2000

Therapy/Procedure

6Drug Therapy (Chemotherapy)
08/2010 - 06/2000
3Therapeutics
04/2002 - 11/2000
2Radiotherapy
07/2006 - 12/2000
1Contact Lenses
10/2009
1Proton Therapy
07/2006
1Brachytherapy
07/2006
1Phacoemulsification
06/2006
1Intraocular Lenses (Intraocular Lens)
06/2006
1Vitrectomy
04/2005
1Combination Drug Therapy (Combination Chemotherapy)
12/2003
1Cataract Extraction
04/2002